. Author manuscript; available in PMC: 2014 Mar 24.

Published in final edited form as: Clin Genitourin Cancer. 2012 Jun 12;10(4):232–238. doi: 10.1016/j.clgc.2012.05.001

Table 5.

Summary of Treatment-Emergent Adverse Events Leading to Study Discontinuation

Adverse Event	Grade	Relationship to Study Drug	Outcome After Discontinuation
Mucosal Inflammation	2	Definitely related	Resolved
Thrombocytopenia	3	Probably related	Resolved
Weight Decrease	1	Probably related	Continuing effect
Pneumonitis	1	Possibly related	Resolved
Neutropenia	3	Probably related	Resolved
Urinary Bladder Hemorrhage	3	Probably not related	Resolved
Fatigue	3	Probably not related	Resolved
Pulmonary Embolism	3	Not related	Resolved, with sequelae